Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_assertion description "[In this study, we found that cancer-associated fibroblasts (CAF) but not normal fibroblasts (NF) secrete high level of IL-6 with activated STAT3 and appear senescent at early passages in culture or in cervical cancer tissues infected with high-risk HPV, and that treatment of NF with recombinant IL-6 or CAF conditioned medium (CM) induces activation of STAT3 and cellular senescence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_assertion evidence source_evidence_literature NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_assertion SIO_000772 23953057 NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_assertion wasDerivedFrom befree-20140225 NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_assertion wasGeneratedBy ECO_0000203 NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP921937.RAyhMAbK5FuA1EkSC2uFzjps8XJVsCrTVyvy1gXihgRaE130_provenance.